Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products
- 1 September 2011
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1812 (9) , 1130-1137
Abstract
No abstract availableKeywords
Funding Information
- Basic Research Program of Shanghai (08JC1419900)
- NIH (1R43 CA103553-01)
- The Department of Defense (W81XWH-04-1-0597)
- California Institute of Regenerative Medicine (CIRM) (RT2-01942)
This publication has 70 references indexed in Scilit:
- Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in RatsLipids in Health and Disease, 2011
- Comparison of Fibrate, Ezetimibe, Low- and High-Dose Statin Therapy for the Dyslipidemia of the Metabolic Syndrome in a Mouse ModelAngiology, 2011
- In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cellsFertility and Sterility, 2010
- Effects of α‐lipoic acid on endothelial function in aged diabetic and high‐fat fed ratsBritish Journal of Pharmacology, 2008
- Beyond Lipid Lowering: What Have We Learned About the Benefits of Statins from the Acute Coronary Syndromes Trials?The American Journal of Cardiology, 2006
- Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetesClinical and Experimental Medicine, 2006
- C-Reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression in Human Endothelial CellsHypertension, 2006
- Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitorsClinical Immunology, 2006
- Effects of Statins on 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Beyond Low-Density Lipoprotein CholesterolThe American Journal of Cardiology, 2005
- Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)Journal of Biological Chemistry, 2004